title: [Therapeutic efficacy of compound Xuanju capsule on type III prostatitis].
abstract: OBJECTIVE
  To evaluate the therapeutic effect of Compound Xuanju Capsule on type III prostatitis.
  
  
  METHODS
  A total of 242 patients with type III prostatitis diagnosed by the NIH criteria were randomly divided into an experimental and a control group of equal number, the former treated with Compound Xuanju Capsule + Tamsulosin Hydrochloride, and the latter with Quinolinone antibiotics + Tamsulosin and Hydrochloride, both for 6 months. After treatment, we assessed the therapeutic effects based on the NIH-CPSI scores and the improvement of relevant complications.
  
  
  RESULTS
  All the 242 patients completed the treatment. The total effectiveness rate was 77.69% (94/121) in the experimental group, 71.56% (78/109) in those with complications. In comparison, it was only 47.10% (57/121) in the control group, 31.78% (34/107) in those with complications. Both the NIH-CPSI scores and the improvement of complications were significantly higher in the experimental than in the control group (P < 0.05).
  
  
  CONCLUSIONS
  Compound Xuanju Capsule has a good therapeutic effect on type III prostatitis.
authors.affiliation: Department of Urology, Qingdao Jiaozhou Central Hospital, Jiaozhou, Shandong 266300, China. penggping@163.com
authors.forename: Guang-Ping
authors.initials: GP
authors.lastname: Peng
authors.forename: De-Zhu
authors.initials: DZ
authors.lastname: Qi
authors.forename: Ke-Qing
authors.initials: KQ
authors.lastname: Hu
authors.forename: Zeng-Yi
authors.initials: ZY
authors.lastname: Liu
authors.forename: Pei-Geng
authors.initials: PG
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D011472:Prostatitis / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004365:Drugs, Chinese Herbal